Creo Medical (GB:CREO) has released an update.
Creo Medical Group plc, a medical device company specializing in surgical endoscopy, has announced the publication of its 2023 Annual Report and Accounts and the upcoming Annual General Meeting (AGM) scheduled for 26 June 2024. Shareholders are encouraged to vote by proxy and can appoint the Chair to ensure their vote is counted. The CEO will present at the AGM, with the assurance that no new material information will be disclosed.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
